• Major advances in understanding EEHV biology, EEHV Hemorrhagic disease diagnosis and treatment, and immunity to EEHV have been made in the last two decades. These advances were made possible by funding and samples provided by North American and European zoological institutions.
  • Recent advances in the ability to measure antibody levels against EEHV are a new tool to better identify elephants with the lowest immunity, and highest risk of EEHV Hemorrhagic Disease.